Understanding large molecular networks consisting of entities such as genes, proteins or RNAs that interact in complex ways to drive the cellular machinery has been an active focus of systems biology. Computational approaches have played a key role in systems biology by complementing theoretical and experimental approaches. Here we roadmap some key contributions of computational methods developed over the last decade in the reconstruction of biological pathways. We position these contributions in a 'systems biology perspective' to reemphasize their roles in unravelling cellular mechanisms and to understand 'systems biology diseases' including cancer.
Introduction
To understand the functional organisation of cells or higher biological units, often it is beneficial to conceptualize them as systems of interacting entities. For such a systems-level description, one needs to know (a) the entities ("parts list") that constitute the system, (b) the interactions among these entities, and (c) their dynamic behaviour under changes to internal and external conditions [1] . The goal of systems biology is to combine all this information into models that capture current knowledge and provide new insights and predictions about the system under previously unstudied conditions [2] . Early attempts at systems biology suffered from inadequate data to build reliable models and formulate hypotheses; however, the recent advent of high-throughput technologies has brought the initial wave of data to revive systems-level modelling and analysis, thereby seeding a revolutionary change in how biology is being studied and understood.
Understanding of complex molecular networks consisting of entities such as genes, proteins or RNAs connected by interactions for regulation or synthesis in cellular decision-making and responses has become a key focus of systems-level studies. Efficient computational approaches can complement theoretical and experimental approaches to model, analyse and distil knowledge from high-throughput data. The reconstruction of biological pathways through which cellular entities interact, signal and regulate cellular processes is certainly one of the fundamental building blocks towards understanding whole biological networks.
Understanding computational methods in a systems biology setting
In order to decipher the correct and complete picture of cellular organisation, it is imperative to assess the entire collection of pathways as a whole rather than individually; the system as a whole has emergent properties that are not visible at the parts level [3] .
However the reconstruction of all pathways, together with their intricate network of crosstalk and feedback loops, is a daunting task. Since pathways do not have definite start and end points or distinct boundaries, modeling them computationally is a significant challenge.
Nevertheless, all computational methods developed to date model pathways as definite computable structures such as paths, trees or subnetworks. Under these circumstances, it becomes all the more crucial to place these computational methods and their contributions in a systems biology setting to assess where we stand in achieving this higher goal of systems-level understanding of cellular organisation.
In this article, we roadmap some of the key computational methods devised over the last decade for biological pathway reconstruction from high-throughput data. Although we mainly look at methods reconstructing regulatory or signalling pathways, this illustrates how computational methods have contributed to this area more broadly. While some methods have focused on identifying general pathways, others have specifically considered dysregulated and disease pathways, while still others have looked at additive, alternative or compensatory relationships among pathways. Further, as these methods evolved, so did their mechanisms to integrate diverse "omics" data, mainly genomics (gene expression, methylation, mutation, regulation, genetic interaction) and proteomics (protein interaction).
It is both imperative and interesting to put all these developments together and consider where we stand in deciphering systems-level molecular networks and evaluate its implications.
General pathway identification
In an elegant study [4] protein-DNA interactions were being catalogued for yeast [5] , and this enabled Ideker et al.
to assemble a global network of ~3000 interactions. This network was used to identify paths connecting perturbed GAL genes to every other affected gene. They identified nine genes involved in glycogen accumulation and protein metabolism, and several of unknown function, that responded strongly to galactose induction.
As more high-throughput protein interaction [5] [6] [7] and gene expression data [8] began to appear, Steffen et al. [9] in 2002 took a similar approach, assembling a large PPI network to draw possible linear paths of specified lengths starting at membrane proteins and ending on DNA-binding proteins. They scored these paths using co-expression among adjacent proteins to identify high-ranking paths corresponding to known pathways. This method, called NetSearch, enabled them to reconstruct the yeast MAPK (mitogen-activated protein kinases) pathways involved in pheromone response, filamentous growth, and maintenance of cell wall integrity. Similarly, Liu et al. [10] identified candidate sets of proteins in a PPI network, and inferred the highest-scoring order among them by measuring gene coexpression among adjacent proteins in each permutation of the set. With this scoring, they could identify the correct ordering among proteins that corresponded to MAPK pathways in yeast. In a separate attempt, Friedman et al. [11, 12] used a Bayesian framework to learn expression profiles of genes perturbed in yeast mutants and used it to infer pairwise expression correlation among proteins. Through this they assembled pathways involved in purine biosynthesis and non-homologous DNA double strand break repair.
Alongside yeast, large-scale PPI data from prokaryotes including Helicobacter pylori [13] and eukaryotes including Caenorhabditis elegans [14] began to appear around 2001-2002, which enabled researchers to search in networks for pathways conserved across species. In a seminal work of this kind, Kelley et al. [15] in 2003 devised PATHBLAST, an efficient tool to align paths across multiple PPI networks. This tool enables search for homologous paths across networks by accommodating "gaps" and "mismatches". They identified 150 homologous paths of lengths ≥4 among the three species. Further, by self-matching the yeast network, Kelley et al. identified about 300 paralogous paths that they grouped into several functional pathways. Following this success, Shlomi et al. [16] proposed QPath, which improved on the results of PATHBLAST.
In the meantime, as reports [17, 18] of high false-positive rates in high-throughput experiments began to surface, it became necessary to assess reliability of interactions before employing them in focused studies such as pathway identification. In a seminal study combining reliability scoring and pathway identification, Scott et al. [19] Through experiments on a yeast network of ~4500 proteins and ~14500 interactions, they successfully reconstructed several pheromone-response pathways with high accuracy.
Aided by computational tools and experimental approaches, the growth of public databases including KEGG [20] for pathways and FunCat [21] and Gene Ontology (GO) [22] for functional annotations enabled pathway identification methods to use these annotations for both prediction and validation of results. Among the first to use such diverse data was PathFinder by Bebek et al. [23] in 2007. These authors collected functional annotations from FunCat and GO for proteins in KEGG to build functional templates for pathways. They then used these templates to mine pathways from the yeast PPI network, and the high-support pathways were identified and scored using association rules mining [24] . PathFinder showed significantly better accuracy and sensitivity compared to most earlier methods, and identified several missing links among proteins in annotated pathways in databases.
In an attempt to identify general substructures beyond linear paths, Zhao et al. [25] in 2008 devised an integer linear programming (ILP)-based approach to mine the yeast PPI network.
They modeled pathways as compact subnetworks between fixed starting and ending points.
These subnetworks were scored using reliability scores on the edges: linear paths were scored as the sum of the edges in the paths, while general subnetworks were scored as the sum of the constituent edges. An ILP-based model was then proposed to extract highscoring subnetworks from the PPI network. Experiments on subnetworks identified between membrane proteins and transcription factors showed that many pheromone-response pathways and signalling pathways for filamentous growth were reconstructed with high accuracy.
Liu et al. [26] (2009) noticed that most signals between proteins (for example activation, inhibition, phosphorylation, dephosphorylation and ubiquitination) were directional, so identifying the correct direction of interactions among proteins was crucial for accurate reconstruction of signalling pathways. They proposed a signal-flow model to orient interactions in the PPI network, for which they used domain interaction information among proteins. Based on the deduced orientations, they identified potential upstreamdownstream relationships within protein pairs. This method successfully reconstructed several signalling pathways from the human PPI network, which matched ones annotated in KEGG and other databases.
Independent to these approaches, Boolean [27, 28] , Petri Nets [29] and ordinary differential equations (ODEs) [30] are a few other models that were proposed, but these have mainly focused on simulation and study of behavior of known pathways as against pathway inference from high-throughput datasets.
Exploring relationships among pathways
As methods to identify pathways improved, it became interesting to understand the relationships among different pathways and how they constituted the larger "pathway network" to regulate and govern cellular processes. This was further fuelled by the realisation that many diseases, including cancer, arise from a complex interplay between pathways acting in additive, compensatory or alternative ways to maintain aberrant behaviour of cells. While the genomics and proteomics data had already proven useful, the availability of genetic-interaction data from systematic knock-out experiments in yeast and other organisms [31] [32] [33] further aided these studies.
Among the seminal works in this direction, Kelley and Ideker [34] BPM prompted further work to look at PPI and GI interactions in an integrated manner to decipher such pathway relationships. One of the early works that took this forward was by Ulitsky and Shamir [35] (2007), who assembled a large network combining PPI and GI data, and systematically searched for BPM structures. They found that several of the pathways in KEGG [28] were related by BPM structures, indicating that these pathways functioned in a compensatory fashion. BPM relationships between proteins in different complexes with 'pivot' or shared proteins among the complexes were essential to all the host complexes.
Subsequently Hescott et al. [36] (2009) integrated gene-expression data to evaluate BPM structures identified from PPI and GI networks in order to further refine redundant pathway identification. 
In this context, a subset of genetic interactions called synthetic lethality (SL) interactions
have gained immense interest due to their prominence in connecting compensatory pathways and functions. Le Meur and Gentleman (2008) [37] analysed the enrichment of SL interactions within and between complexes and pathways; most SL interactions were between-pathway and -complexes, while a considerable number were also within these structures (see Figure 1) . These within-complex and -pathway interactions ensured internal robustness to these structures by buffering the functions of proteins. In separate work, Ma et al. (2008) [38] proposed that finding bipartite connected subnetworks or bicliques in SL networks can help to identify groups of proteins belonging to redundant pathways. To this end, they searched for bicliques among SL interactions, and were able to identify several interesting relationships between pathways governing functions including DNA repair and DNA replication, and tubulin folding and mitosis. Brady et al. (2009) [39] further extended this approach to search for structures that they called stable bipartite subgraphs, and identified several new pairs of redundant pathway relationships.
Pathways in dysregulated functions and diseases
Many diseases, including cancer, result from dysregulated pathways and their complex interactions, and it is becoming increasingly clear that mapping these pathways is crucial to fully understand these complex diseases. This requires integrating diverse information from gene expression, mutation and regulation, protein interaction datasets and others; this has prompted integrative or "multi-omics" research towards pathway identification. Early work Following these approaches, several methods were devised to simulate flows to identify paths between causal and target genes. An important method by Suthram et al. [42] in 2008 used electric-circuit-based modelling [43] to simulate flows in the network. The motivation was that the random-walk-based methods were stochastic and required many simulations (about 10000 times in Tu et al.) to determine the causal gene. To propose a deterministic steady-state solution, Suthram et al. equated these random walks to the flow of electric current, and solved the network using electric-circuit theory (Kirchhoff's and Ohm's Laws).
Equating the amount of current flow through each node and edge in the network to the expression level and importance of the genes, they could determine the 'true' causal genes with high accuracy.
The electric circuit method was successfully adopted by Kim et al. (2009) [44] in the study of glioblastoma multiforma. They selected a set of differentially expressed target genes that covered 158 glioblastoma cases, and then identified possible genomic loci harbouring causal genes responsible for the differential expression of target genes. By overlaying a human PPI network, Kim et al. found probable paths from target to causal genes for which they used the electric-circuit model of Suthram et al. The causal genes identified were then evaluated for the disease cases they covered. Gene Ontology-based analysis of the identified pathways showed high enrichment of processes involved in glioblastoma. Following this success, He et al. [45] used a similar approach to identify dysfunctional genes and modules in congenital heart disease (CHD).
Role of computational methods in future breakthroughs
Among the kinds of genetic interactions, synthetic lethality (SL) describes a scenario in which single-gene defects are compatible with cell viability but a combination of gene defects results in cell death [46] . In essence, these SL interactions provide functional buffering, sometimes described as genetic canalisation, that is, buffering of pathways against the tendency of new alleles or mutated genes to make non-optimal phenotypes [47] . With the assembling of major pathways involved in core cellular processes affected in cancer, including DNA replication, DNA damage repair and cell-cycle checkpoints, it is now clear that buffering among pathways maintains viability in cancerous cells, potentially weakening anti-cancer therapies aimed at blocking individual pathways. However on the positive side, this hints that "sweet spots" capable of overcoming such compensatory arrangements can be identified that may lead to effective anti-cancer strategies in the future [48] .
The PARP/BRCA relationship has become the poster child for SL-based cancer research today [48, 49] . BRCA1 is a large protein expressed during the S and G2 phases of the cell Although the PARP/BRCA relationship is only a conditional one and not a panacea, it reflects the extent and kind of intricate relationships that need to be deciphered to map and understand the "pathway network", and therefore to understand diseases like cancer. As
Laubenbacher et al. [3] rightly put it as, "cancer is a systems biology disease". While our current knowledge of pathways in cancer is still incomplete, immense efforts are underway to identify new players (genes, proteins and whole pathways) as well as to implicate existing 
Conclusions
In order to decipher a correct and complete picture of cellular organisation, it is necessary to take a systems-level view. Mapping the molecular network is a crucial step toward this goal. However, mapping the entire network at one go can be daunting (and the current data are inadequate to support this), so mapping individual pathways is a rational way to proceed. Having said that, knowledge of individual pathways must be reflected back to the systems-level context, lest we miss the bigger picture.
Computational approaches have played a key role in identification and mapping of pathways. In this article, by drawing a roadmap of key contributions from computational approaches, and describing instances in which collective understanding of multiple pathways is necessary (for example, in cancer), we have attempted to put all these developments in a systems-level perspective. Future breakthroughs in understanding cellular mechanisms and diseases can come only by taking such a systems-level view. To this end, computational approaches will continue to play a key role.
Key Points
 Mapping the network of genes, proteins, RNA, and other molecules is a crucial step towards realizing the 'systems biology goal' of understanding cellular organisation.
 Computational methods play a key role in this by complementing theoretical and experimental approaches.
 We have highlighted key contributions of computational approaches in identification of signalling/regulatory pathways. These approaches have gone hand-in-hand with the improvements in high-throughput techniques, and have integrated diverse "omics" datasets.
 Through these contributions, we reemphasize that computational methods have a key role in future breakthroughs in understanding cellular organization and also complex systems-level diseases like cancer.
